Non-Invasive Cancer Treatment:
13.56 MHz Modulated RF Hyperthermia (mHT)

Radiofrequency (RF) hyperthermia is an innovative and completely non-invasive oncology intervention. Using 13.56 MHz electromagnetic waves to selectively target malignant cells, it sensitizes tumors to standard therapies without physical trauma. The non-invasive nature is a clinical advantage: no surgical incisions, needles, or punctures are required.

HyDeep 600WM Modulated RF Hyperthermia Device - Non-Invasive Cancer Therapy
The Andromedic HyDeep 600WM advanced oncologic hyperthermia device perfectly illustrates the non-invasive nature of mHT, providing maximum patient comfort with no surgical instruments inserted into the body.

Peer-reviewed clinical studies demonstrate that integrating mHT into oncology protocols improves Overall Survival (OS), Local Tumor Control (LTC), and Patient Quality of Life. (Scientific Reference)

Biophysical Mechanisms & Clinical Benefits of Modulated RF

The mechanism of Modulated RF hyperthermia is multifaceted, influencing the tumor microenvironment (TME) and the systemic immune response, maintaining a strictly non-invasive profile.

Clinical Synergy: Enhancing Standard Oncological Therapies

1. Synergy with Chemotherapy (Perfusion)

mHT triggers localized vasodilation within the tumor microcirculation, facilitating superior intratumoral perfusion of cytotoxic agents.

Therapeutic Impact: Potentiates chemotherapy efficacy without increasing systemic toxicity.

2. Radiosensitization (Reoxygenation)

By improving intratumoral oxygenation, mHT eliminates radioresistant hypoxic fractions, making tumor cells significantly more susceptible to radiotherapy.

Radiosensitizing Effect: Enhances radiation response via a patient-friendly, non-aggressive protocol.
Advanced Immuno-Oncology

Immune System Activation via Modulated RF

Modulated RF hyperthermia is a catalyst for the anti-tumor immune response through biological signaling pathways.

Immunogenic Cell Death (ICD) & DAMPs

mHT induces ICD, triggering the release of Damage-Associated Molecular Patterns (DAMPs). These signals alert the immune system and promote long-term immunological memory through a non-invasive stimulus.

Systemic Impacts: The Abscopal Effect

Local mHT treatment can induce systemic anti-tumor responses in distant metastatic sites, acting as a non-invasive partner to checkpoint inhibitors.

Clinical Applications: A Gentle Option for Every Stage

Adjuvant & Neoadjuvant Support

Boosts the success rate of primary treatments without adding invasive burden to the clinical protocol.

Palliative Care & Pain Management

Significantly reduces cancer-related pain. Its gentle nature improves Quality of Life (QoL) in advanced-stage oncology.

Inflammatory Pathologies

Treats chronic inflammation and concomitant pathologies through the same safe, non-invasive technology.

Clinical Evidence & Future Perspectives

Modulated RF hyperthermia (mHT) is a vital evidence-based therapy that maximizes efficacy through a non-invasive method that respects patient well-being.

mHT